Potassium Cyanide → methyl (S)-11,12,13,13a-tetrahydro-9-oxo-9H-imidazo[1,5-a]pyrrolo[2,1-c][1,4]benzodiazepine-1-carboxylate

HRID 67326

Reaktionsgleichung

Reaktionsgleichung von HRID 67326
[O:1]=[C:2]1[C:8]2[CH:9]=[CH:10][CH:11]=[CH:12][C:7]=2[N:6]2[CH:13]=[N:14][C:15]([C:16]([O:18][CH2:19]C)=[O:17])=[C:5]2[C@@H:4]2[CH2:21][CH2:22][CH2:23][N:3]12.[C-]#N.[K+]>CO>[O:1]=[C:2]1[C:8]2[CH:9]=[CH:10][CH:11]=[CH:12][C:7]=2[N:6]2[CH:13]=[N:14][C:15]([C:16]([O:18][CH3:19])=[O:17])=[C:5]2[C@@H:4]2[CH2:21][CH2:22][CH2:23][N:3]12

Komponenten

4

Versuchsvorschrift

A mixture of 311 mg (1 mmol) of ethyl (S)-11,12,13,13a-tetrahydro-9-oxo-9H-imidazo[1,5-a]pyrrolo[2,1-c][1,4]benzodiazepine-1-carboxylate, 66 mg of potassium cyanide and 10 ml of absolute methanol is heated to boiling under reflux for 6 hours. The mixture is concentrated, a small amount of water is added, the mixture is extracted three times with 10 ml of chloroform each time, dried over magnesium sulphate, evaporated and recrystallised from ethyl acetate/hexane. There is obtained methyl (S)-11,12,13,13a-tetrahydro-9-oxo-9H-imidazo[1,5-a]pyrrolo[2,1-c][1,4]benzodiazepine-1-carboxylate of melting point 165°-167° C.

Aufarbeitung

  1. temperatureis heated
  2. temperatureunder reflux for 6 hours
  3. concentrationThe mixture is concentrated
  4. additiona small amount of water is added
  5. extractionthe mixture is extracted three times with 10 ml of chloroform each time
  6. dry with materialdried over magnesium sulphate
  7. customevaporated
  8. customrecrystallised from ethyl acetate/hexane

Quellen und Nachweise

ORD-Eintrag
ord-4055084d42d44de49463c118df15d0aa
Quelldatensatz
uspto-grants-1982_08
Patentnummer
US04346030

Verknüpfte Notizen

Wird geladen…